Skip to Main Content

Paper Details

Preclinical efficacy and safety of an anti-IL-1β vaccine for the treatment of type 2 diabetes.
Mol Ther Methods Clin Dev
37
2014
Author NameAffiliation
Reto GulerInternational Centre for Genetic Engineering and Biotechnology (ICGEB) and Institute of Infectious Diseases and Molecular Medicine (IDM), University of Cape Town
  • 1 - 1

Datasets

Release 1.2